CA
NZ
UK
AU
IND
US
AbbVie Inc. (NYSE:ABBV) shares are declining today after the company reported strong second-quarter 2026 results but trimmed its full-year adjusted EPS guidance, overshadowing the headline earnings beat. AbbVie, headquartered in North Chicago, Illinois and formed in 2013 as a spin-off from Abbott Laboratories, is …
Integer Holdings (NYSE:ITGR) shares are surging today after a Wall Street Journal report, citing people familiar with the matter, said private equity firm KKR is nearing a deal to acquire the company, with terms valuing Integer at approximately $127 per share. Integer Holdings, headquartered …
SCYNEXIS, Inc. (NASDAQ:SCYX) penny stock shares are surging today, extending recent gains as investor attention builds around the company's Phase 1 study of SCY-770, a first-in-class, potent and direct AMP-activated protein kinase activator being developed for Autosomal Dominant Polycystic Kidney Disease. SCYNEXIS, headquartered in …
Alvotech (NASDAQ:ALVO) shares are surging today after the FDA closed its inspection of the company's Reykjavik, Iceland manufacturing facility with a Voluntary Action Indicated classification, a favorable outcome that removes a major regulatory overhang tied to the site. Alvotech, headquartered in Luxembourg and founded …
Mangoceuticals, Inc. (NASDAQ:MGRX) penny stock shares are surging today after the company entered into a definitive business combination agreement with Nuclea Energy Inc., an advanced nuclear technology company developing the Morpheus microreactor, a lead-cooled, factory-built micro-modular reactor. Mangoceuticals, headquartered in Dallas, Texas, is a …
Yarrow Bioscience has executed a strategic exchange involving 133,290 shares of its common stock, which will be swapped for pre-funded warrants. These warrants provide shareholders immediate flexibility in ownership. This move is expected to reshape the company’s equity environment, expanding the shareholder base’s purchasing …
Wave Life Sciences Ltd. posted an EPS of $-0.34 for the quarter ended June 30, 2026, missing the consensus estimate by $0.03. The company’s stock has plummeted 63.9% year-to-date, indicating investors' concerns regarding its financial outlook and pipeline effectiveness.Key HighlightsWave Life Sciences reported an …
Vericel Corp (NASDAQ: VCEL) delivered a solid performance in the second quarter, posting an earnings per share (EPS) of $0.04 for the quarter ending June 30, 2026, exceeding analyst expectations of a loss of $-0.03. This positive result adds momentum to the company's growth …
Oric Pharmaceuticals, Inc. has taken a significant step to enhance its strategic equity compensation framework by amending its equity incentive plan. As of July 28, 2026, the company’s Board of Directors approved the inclusion of an additional 1.1 million shares, bringing the total reserved …
Penumbra Inc. (NYSE: PEN) reported its second-quarter earnings, revealing an earnings per share (EPS) of $0.88 for the period ending June 30, 2026. This figure falls short of the analyst consensus estimate of $1.09, indicating potential concerns amongst investors about the company’s financial trajectory …
Please wait processing your request...